CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is participating in a clinical trial for a newly developed
medication. Which statement best describes the primary
purpose of conducting randomized controlled clinical trials
before a drug receives regulatory approval?
A. To determine whether the medication can be manufactured
at low cost
B. To evaluate the medication's safety and effectiveness in
human participants
C. To compare marketing strategies with competing medications
D. To establish the medication's over-the-counter availability
Correct Answer: B
Rationale:
Randomized controlled clinical trials are designed to evaluate
the safety and effectiveness of a medication in carefully
selected human participants before regulatory approval. These
studies help identify therapeutic benefits, adverse effects, and
appropriate dosing. Option A relates to manufacturing
considerations rather than clinical evaluation. Option C
concerns commercial issues rather than scientific evidence.
Option D is determined after regulatory review and depends on
multiple factors beyond clinical trial results.
,Question 2
A nurse is reviewing the phases of clinical drug development
with a newly hired colleague. Which study primarily focuses on
determining the safety, tolerability, and dosage range of a
medication in humans?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Correct Answer: A
Rationale:
Phase I studies are the first human trials and primarily evaluate
safety, tolerability, pharmacokinetics, and appropriate dosage
ranges. Phase II studies assess preliminary effectiveness while
continuing safety evaluation. Phase III studies compare the
medication with existing therapies or placebo in larger
populations to support regulatory approval. Phase IV studies
occur after approval and monitor long-term safety and
effectiveness in the general population.
Question 3
A nurse is teaching a patient about generic medications. Which
information should the nurse include?
, A. Generic medications are required to demonstrate
comparable bioavailability to the reference product.
B. Generic medications always produce fewer adverse effects
than brand-name medications.
C. Generic medications contain different active ingredients than
brand-name medications.
D. Generic medications are never therapeutically equivalent to
brand-name medications.
Correct Answer: A
Rationale:
Generic medications are expected to demonstrate
bioequivalence, meaning comparable bioavailability and
therapeutic performance to the approved reference product.
They contain the same active ingredient, strength, dosage form,
and route of administration. Adverse effects are generally
expected to be similar, making Option B incorrect. Option C is
incorrect because the active ingredient remains the same.
Option D is incorrect because approved generics are considered
therapeutically equivalent when bioequivalence requirements
are met.
Question 4
A patient asks why a medication carries a boxed warning. Which
response by the nurse is most appropriate?